Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study

about

Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study

Item

http://www.wikidata.org/entity/Q56526696

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Association between proprotein ...... fting: a cross-sectional study

@en

Association between proprotein ...... fting: a cross-sectional study

@nl

type

Item

label

Association between proprotein ...... fting: a cross-sectional study

@en

Association between proprotein ...... fting: a cross-sectional study

@nl

prefLabel

Association between proprotein ...... fting: a cross-sectional study

@en

Association between proprotein ...... fting: a cross-sectional study

@nl

P1476

Association between proprotein ...... fting: a cross-sectional study

@en

P2093

Hai-Bo Wang

http://www.w3.org/2001/XMLSchema#string

Jian-Yong Xiao

http://www.w3.org/2001/XMLSchema#string

Jing Gao

http://www.w3.org/2001/XMLSchema#string

Kathleen Heather Reilly

http://www.w3.org/2001/XMLSchema#string

Min Ren

http://www.w3.org/2001/XMLSchema#string

Yin Liu

http://www.w3.org/2001/XMLSchema#string

Yu-Ming Li

http://www.w3.org/2001/XMLSchema#string

P2860

The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

PCSK9: a key modulator of cardiovascular health

PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future

Inflammation and atherosclerosis

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor.

The role of the LDL receptor in apolipoprotein B secretion.

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.

P304

e021951

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2018-021951

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29991632

http://www.w3.org/2001/XMLSchema#string

P921

coronary artery bypass surgery

P932

6089317

http://www.w3.org/2001/XMLSchema#string